RUSSLAN STUDY INVESTIGATORS. SAFETY AND EFFICACY OF A NOVEL CALCIUM SENSITIZER, LEVOSIMENDAN, IN PATIENTS WITH LEFT VENTRICULAR FAILURE DUE TO AN ACUTE MYOCARDIAL INFARCTION. A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY (RUSSLAN)

Publication | Closed Access

Citations

References

2002

Year

V.S. Moiseyev, Pentti Põder, Nikolajs Andrejevs, Michail Y. Ruda, А П Голиков, Л. Б. Лазебник, Zhanna Kobalava, Lasse Lehtonen, Tanja Laine, Nieminen,

Unknown Venue

Heart FailureCardiovascular DiseaseA RandomizedMedicineMyocardial InfarctionCardiovascular PharmacologyPharmacotherapyRusslan Study InvestigatorsPharmacologyCardiologyAcute Myocardial InfarctionSafety And Efficacy